Axogen (AXGN) Income from Continuing Operations (2010 - 2026)
Axogen (AXGN) recorded quarterly Income from Continuing Operations of 2758000.0 in Q1 2026, up 75.24% quarter-over-quarter from 11138000.0 in Q4 2025, and up 24.21% on a YoY basis from 2220434.07 in Q1 2025.
Axogen (AXGN) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Axogen's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 2758000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 24.21% year-over-year to 2758000.0; the TTM figure through Mar 2026 stood at 13502000.0 (down 82.53% YoY), while the FY2025 annual figure was 14383000.0, down 38.94% from the prior year.
- Income from Continuing Operations was 2758000.0 for Q1 2026 at Axogen, up from 11138000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 541000.0 in Q4 2024 to a low of 11720000.0 in Q1 2022.
- Historically, Income from Continuing Operations has averaged 4709588.24 across 5 years, with a median of 4701000.0 in 2023.
- Biggest YoY gain for Income from Continuing Operations was 124.78% in 2025; the steepest drop was 2158.78% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 5171000.0 in 2022, then grew by 9.09% to 4701000.0 in 2023, then jumped by 111.51% to 541000.0 in 2024, then slumped by 2158.78% to 11138000.0 in 2025, then surged by 75.24% to 2758000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 2758000.0 (Q1 2026), 11138000.0 (Q4 2025), and 474000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Axogen | 2.32 Bn | 2.22 Bn | 46.19 Mn | -2.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.76 Mn |
| Dec 31, 2025 | -11.14 Mn |
| Sep 30, 2025 | 474,000.00 |
| Jun 30, 2025 | -80,000.00 |
| Mar 31, 2025 | -3.64 Mn |
| Dec 31, 2024 | 541,000.00 |
| Sep 30, 2024 | -1.91 Mn |
| Jun 30, 2024 | -2.39 Mn |
| Mar 31, 2024 | -6.59 Mn |
| Dec 31, 2023 | -4.70 Mn |
| Sep 30, 2023 | -4.49 Mn |
| Jun 30, 2023 | -6.82 Mn |
| Mar 31, 2023 | -6.81 Mn |
| Dec 31, 2022 | -5.17 Mn |
| Sep 30, 2022 | -4.73 Mn |
| Jun 30, 2022 | -8.14 Mn |
| Mar 31, 2022 | -11.72 Mn |
| Dec 31, 2021 | -5.27 Mn |
| Sep 30, 2021 | -7.09 Mn |
| Jun 30, 2021 | -7.69 Mn |